BUPE for Recovery Act
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The BUPE for Recovery Act requires the Drug Enforcement Administration to temporarily exempt buprenorphine products from the Suspicious Orders Report System until 270 days after the opioid public health emergency expires. The bill directs the Departments of Justice and Health and Human Services to report within 90 days of the emergency's expiration on whether the exemption increased access to buprenorphine treatment and to recommend whether the exemption should become permanent. The bill reflects congressional concern that reporting requirements have discouraged pharmacies from stocking buprenorphine, limiting patient access to opioid use disorder treatment.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.